Global Gene Therapy Market Research Report 2026(Status and Outlook)
Gene therapy is an experimental treatment that involves introducing genetic material into a person’s cells to fight or prevent disease. Researchers are studying gene therapy for a number of diseases, such as severe combined immuno-deficiencies, hemophilia, Parkinson's disease, cancer and even HIV, through a number of different approaches. A gene can be delivered to a cell using a carrier known as a “vector.” The most common types of vectors used in gene therapy are viruses. The viruses used in gene therapy are altered to make them safe, although some risks still exist with gene therapy. The technology is still in its infancy.The Gene Therapy market is driven by the growing demand for innovative treatments for rare genetic disorders, cancers, and chronic diseases that lack effective conventional therapies. Advancements in gene editing technologies such as CRISPR/Cas9, improved viral and non-viral delivery vectors, and increasing knowledge of the human genome have made gene therapy a promising option in precision medicine. Regulatory agencies are also offering accelerated approval pathways for breakthrough gene therapies, encouraging investment and speeding up clinical development. In addition, rising public and private funding, along with successful commercialization of landmark therapies like Zolgensma and Luxturna, are fueling confidence and expansion in this market.Despite its potential, the Gene Therapy market faces several critical challenges, including high development and treatment costs, complex manufacturing processes, and safety concerns. Producing gene therapies requires highly specialized facilities and stringent quality control, leading to limited scalability and high prices, which can exceed millions of dollars per patient. Furthermore, long-term safety data are still lacking, with concerns over immune responses, off-target effects, and durability of treatment outcomes. Regulatory, ethical, and reimbursement hurdles also pose significant barriers to broader adoption. Addressing these challenges is essential to ensure accessibility, affordability, and the long-term success of gene therapy as a mainstream medical solution.Global Gene Therapy key players include Biogen, Novartis, Gilead Sciences, etc. Global top three manufacturers hold a share about 75%. North America is the largest market, with a share about 60%, followed by Europe and Asia-Pacific, both have a share about 35 percent. In terms of product, Non-viral Gene Therapy is the largest segment, with a share about 55%. And in terms of application, the largest application is Neurological Diseases, followed by Cancer.
The global Gene Therapy market size was estimated at USD 11480.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 27.60% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Gene Therapy market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Gene Therapy market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Gene Therapy market.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Gene Therapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Gene Therapy, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
The global Gene Therapy market size was estimated at USD 11480.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 27.60% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Gene Therapy market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Gene Therapy market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Gene Therapy market.
Global Gene Therapy Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
- Biogen
- Novartis
- Gilead Sciences
- Sarepta Therapeutics
- Alnylam Pharmaceuticals
- Amgen
- Roche
- Akcea Therapeutics
- bluebirdbio
- Sunway Biotech
- SIBIONO
- AnGes
- Orchard Therapeutics
- Human Stem Cells Institute
- CSL Behring
- BioMarin Pharmaceutical
Market Segmentation (by Type)
- Viral Gene Therapy
- Non-Viral Gene Therapy
Market Segmentation (by Application)
- Neurological Diseases
- Cancer
- Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Gene Therapy Market
Overview of the regional outlook of the Gene Therapy Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Gene Therapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Gene Therapy, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Gene Therapy
1.2 Key Market Segments
1.2.1 Gene Therapy Segment by Type
1.2.2 Gene Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GENE THERAPY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Gene Therapy Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Gene Therapy Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GENE THERAPY MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Gene Therapy Product Life Cycle
3.3 Global Gene Therapy Sales by Manufacturers (2020-2025)
3.4 Global Gene Therapy Revenue Market Share by Manufacturers (2020-2025)
3.5 Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Gene Therapy Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Gene Therapy Market Competitive Situation and Trends
3.8.1 Gene Therapy Market Concentration Rate
3.8.2 Global 5 and 10 Largest Gene Therapy Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 GENE THERAPY INDUSTRY CHAIN ANALYSIS
4.1 Gene Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF GENE THERAPY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Gene Therapy Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy – April 2025
5.6.3 Global Trade Frictions and Their Impacts to Gene Therapy Market
5.7 ESG Ratings of Leading Companies
6 GENE THERAPY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Gene Therapy Sales Market Share by Type (2020-2025)
6.3 Global Gene Therapy Market Size by Type (2020-2025)
6.4 Global Gene Therapy Price by Type (2020-2025)
7 GENE THERAPY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Gene Therapy Market Sales by Application (2020-2025)
7.3 Global Gene Therapy Market Size (M USD) by Application (2020-2025)
7.4 Global Gene Therapy Sales Growth Rate by Application (2020-2025)
8 GENE THERAPY MARKET SALES BY REGION
8.1 Global Gene Therapy Sales by Region
8.1.1 Global Gene Therapy Sales by Region
8.1.2 Global Gene Therapy Sales Market Share by Region
8.2 Global Gene Therapy Market Size by Region
8.2.1 Global Gene Therapy Market Size by Region
8.2.2 Global Gene Therapy Market Size by Region
8.3 North America
8.3.1 North America Gene Therapy Sales by Country
8.3.2 North America Gene Therapy Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Gene Therapy Sales by Country
8.4.2 Europe Gene Therapy Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Gene Therapy Sales by Region
8.5.2 Asia Pacific Gene Therapy Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Gene Therapy Sales by Country
8.6.2 South America Gene Therapy Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Gene Therapy Sales by Region
8.7.2 Middle East and Africa Gene Therapy Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 GENE THERAPY MARKET PRODUCTION BY REGION
9.1 Global Production of Gene Therapy by Region(2020-2025)
9.2 Global Gene Therapy Revenue Market Share by Region (2020-2025)
9.3 Global Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Gene Therapy Production
9.4.1 North America Gene Therapy Production Growth Rate (2020-2025)
9.4.2 North America Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Gene Therapy Production
9.5.1 Europe Gene Therapy Production Growth Rate (2020-2025)
9.5.2 Europe Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Gene Therapy Production (2020-2025)
9.6.1 Japan Gene Therapy Production Growth Rate (2020-2025)
9.6.2 Japan Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Gene Therapy Production (2020-2025)
9.7.1 China Gene Therapy Production Growth Rate (2020-2025)
9.7.2 China Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Biogen
10.1.1 Biogen Basic Information
10.1.2 Biogen Gene Therapy Product Overview
10.1.3 Biogen Gene Therapy Product Market Performance
10.1.4 Biogen Business Overview
10.1.5 Biogen SWOT Analysis
10.1.6 Biogen Recent Developments
10.2 Novartis
10.2.1 Novartis Basic Information
10.2.2 Novartis Gene Therapy Product Overview
10.2.3 Novartis Gene Therapy Product Market Performance
10.2.4 Novartis Business Overview
10.2.5 Novartis SWOT Analysis
10.2.6 Novartis Recent Developments
10.3 Gilead Sciences
10.3.1 Gilead Sciences Basic Information
10.3.2 Gilead Sciences Gene Therapy Product Overview
10.3.3 Gilead Sciences Gene Therapy Product Market Performance
10.3.4 Gilead Sciences Business Overview
10.3.5 Gilead Sciences SWOT Analysis
10.3.6 Gilead Sciences Recent Developments
10.4 Sarepta Therapeutics
10.4.1 Sarepta Therapeutics Basic Information
10.4.2 Sarepta Therapeutics Gene Therapy Product Overview
10.4.3 Sarepta Therapeutics Gene Therapy Product Market Performance
10.4.4 Sarepta Therapeutics Business Overview
10.4.5 Sarepta Therapeutics Recent Developments
10.5 Alnylam Pharmaceuticals
10.5.1 Alnylam Pharmaceuticals Basic Information
10.5.2 Alnylam Pharmaceuticals Gene Therapy Product Overview
10.5.3 Alnylam Pharmaceuticals Gene Therapy Product Market Performance
10.5.4 Alnylam Pharmaceuticals Business Overview
10.5.5 Alnylam Pharmaceuticals Recent Developments
10.6 Amgen
10.6.1 Amgen Basic Information
10.6.2 Amgen Gene Therapy Product Overview
10.6.3 Amgen Gene Therapy Product Market Performance
10.6.4 Amgen Business Overview
10.6.5 Amgen Recent Developments
10.7 Roche
10.7.1 Roche Basic Information
10.7.2 Roche Gene Therapy Product Overview
10.7.3 Roche Gene Therapy Product Market Performance
10.7.4 Roche Business Overview
10.7.5 Roche Recent Developments
10.8 Akcea Therapeutics
10.8.1 Akcea Therapeutics Basic Information
10.8.2 Akcea Therapeutics Gene Therapy Product Overview
10.8.3 Akcea Therapeutics Gene Therapy Product Market Performance
10.8.4 Akcea Therapeutics Business Overview
10.8.5 Akcea Therapeutics Recent Developments
10.9 bluebirdbio
10.9.1 bluebirdbio Basic Information
10.9.2 bluebirdbio Gene Therapy Product Overview
10.9.3 bluebirdbio Gene Therapy Product Market Performance
10.9.4 bluebirdbio Business Overview
10.9.5 bluebirdbio Recent Developments
10.10 Sunway Biotech
10.10.1 Sunway Biotech Basic Information
10.10.2 Sunway Biotech Gene Therapy Product Overview
10.10.3 Sunway Biotech Gene Therapy Product Market Performance
10.10.4 Sunway Biotech Business Overview
10.10.5 Sunway Biotech Recent Developments
10.11 SIBIONO
10.11.1 SIBIONO Basic Information
10.11.2 SIBIONO Gene Therapy Product Overview
10.11.3 SIBIONO Gene Therapy Product Market Performance
10.11.4 SIBIONO Business Overview
10.11.5 SIBIONO Recent Developments
10.12 AnGes
10.12.1 AnGes Basic Information
10.12.2 AnGes Gene Therapy Product Overview
10.12.3 AnGes Gene Therapy Product Market Performance
10.12.4 AnGes Business Overview
10.12.5 AnGes Recent Developments
10.13 Orchard Therapeutics
10.13.1 Orchard Therapeutics Basic Information
10.13.2 Orchard Therapeutics Gene Therapy Product Overview
10.13.3 Orchard Therapeutics Gene Therapy Product Market Performance
10.13.4 Orchard Therapeutics Business Overview
10.13.5 Orchard Therapeutics Recent Developments
10.14 Human Stem Cells Institute
10.14.1 Human Stem Cells Institute Basic Information
10.14.2 Human Stem Cells Institute Gene Therapy Product Overview
10.14.3 Human Stem Cells Institute Gene Therapy Product Market Performance
10.14.4 Human Stem Cells Institute Business Overview
10.14.5 Human Stem Cells Institute Recent Developments
10.15 CSL Behring
10.15.1 CSL Behring Basic Information
10.15.2 CSL Behring Gene Therapy Product Overview
10.15.3 CSL Behring Gene Therapy Product Market Performance
10.15.4 CSL Behring Business Overview
10.15.5 CSL Behring Recent Developments
10.16 BioMarin Pharmaceutical
10.16.1 BioMarin Pharmaceutical Basic Information
10.16.2 BioMarin Pharmaceutical Gene Therapy Product Overview
10.16.3 BioMarin Pharmaceutical Gene Therapy Product Market Performance
10.16.4 BioMarin Pharmaceutical Business Overview
10.16.5 BioMarin Pharmaceutical Recent Developments
11 GENE THERAPY MARKET FORECAST BY REGION
11.1 Global Gene Therapy Market Size Forecast
11.2 Global Gene Therapy Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Gene Therapy Market Size Forecast by Country
11.2.3 Asia Pacific Gene Therapy Market Size Forecast by Region
11.2.4 South America Gene Therapy Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Gene Therapy by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Gene Therapy Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Gene Therapy by Type (2026-2035)
12.1.2 Global Gene Therapy Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Gene Therapy by Type (2026-2035)
12.2 Global Gene Therapy Market Forecast by Application (2026-2035)
12.2.1 Global Gene Therapy Sales (K Units) Forecast by Application
12.2.2 Global Gene Therapy Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Gene Therapy
1.2 Key Market Segments
1.2.1 Gene Therapy Segment by Type
1.2.2 Gene Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GENE THERAPY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Gene Therapy Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Gene Therapy Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GENE THERAPY MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Gene Therapy Product Life Cycle
3.3 Global Gene Therapy Sales by Manufacturers (2020-2025)
3.4 Global Gene Therapy Revenue Market Share by Manufacturers (2020-2025)
3.5 Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Gene Therapy Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Gene Therapy Market Competitive Situation and Trends
3.8.1 Gene Therapy Market Concentration Rate
3.8.2 Global 5 and 10 Largest Gene Therapy Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 GENE THERAPY INDUSTRY CHAIN ANALYSIS
4.1 Gene Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF GENE THERAPY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Gene Therapy Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy – April 2025
5.6.3 Global Trade Frictions and Their Impacts to Gene Therapy Market
5.7 ESG Ratings of Leading Companies
6 GENE THERAPY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Gene Therapy Sales Market Share by Type (2020-2025)
6.3 Global Gene Therapy Market Size by Type (2020-2025)
6.4 Global Gene Therapy Price by Type (2020-2025)
7 GENE THERAPY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Gene Therapy Market Sales by Application (2020-2025)
7.3 Global Gene Therapy Market Size (M USD) by Application (2020-2025)
7.4 Global Gene Therapy Sales Growth Rate by Application (2020-2025)
8 GENE THERAPY MARKET SALES BY REGION
8.1 Global Gene Therapy Sales by Region
8.1.1 Global Gene Therapy Sales by Region
8.1.2 Global Gene Therapy Sales Market Share by Region
8.2 Global Gene Therapy Market Size by Region
8.2.1 Global Gene Therapy Market Size by Region
8.2.2 Global Gene Therapy Market Size by Region
8.3 North America
8.3.1 North America Gene Therapy Sales by Country
8.3.2 North America Gene Therapy Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Gene Therapy Sales by Country
8.4.2 Europe Gene Therapy Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Gene Therapy Sales by Region
8.5.2 Asia Pacific Gene Therapy Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Gene Therapy Sales by Country
8.6.2 South America Gene Therapy Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Gene Therapy Sales by Region
8.7.2 Middle East and Africa Gene Therapy Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 GENE THERAPY MARKET PRODUCTION BY REGION
9.1 Global Production of Gene Therapy by Region(2020-2025)
9.2 Global Gene Therapy Revenue Market Share by Region (2020-2025)
9.3 Global Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Gene Therapy Production
9.4.1 North America Gene Therapy Production Growth Rate (2020-2025)
9.4.2 North America Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Gene Therapy Production
9.5.1 Europe Gene Therapy Production Growth Rate (2020-2025)
9.5.2 Europe Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Gene Therapy Production (2020-2025)
9.6.1 Japan Gene Therapy Production Growth Rate (2020-2025)
9.6.2 Japan Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Gene Therapy Production (2020-2025)
9.7.1 China Gene Therapy Production Growth Rate (2020-2025)
9.7.2 China Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Biogen
10.1.1 Biogen Basic Information
10.1.2 Biogen Gene Therapy Product Overview
10.1.3 Biogen Gene Therapy Product Market Performance
10.1.4 Biogen Business Overview
10.1.5 Biogen SWOT Analysis
10.1.6 Biogen Recent Developments
10.2 Novartis
10.2.1 Novartis Basic Information
10.2.2 Novartis Gene Therapy Product Overview
10.2.3 Novartis Gene Therapy Product Market Performance
10.2.4 Novartis Business Overview
10.2.5 Novartis SWOT Analysis
10.2.6 Novartis Recent Developments
10.3 Gilead Sciences
10.3.1 Gilead Sciences Basic Information
10.3.2 Gilead Sciences Gene Therapy Product Overview
10.3.3 Gilead Sciences Gene Therapy Product Market Performance
10.3.4 Gilead Sciences Business Overview
10.3.5 Gilead Sciences SWOT Analysis
10.3.6 Gilead Sciences Recent Developments
10.4 Sarepta Therapeutics
10.4.1 Sarepta Therapeutics Basic Information
10.4.2 Sarepta Therapeutics Gene Therapy Product Overview
10.4.3 Sarepta Therapeutics Gene Therapy Product Market Performance
10.4.4 Sarepta Therapeutics Business Overview
10.4.5 Sarepta Therapeutics Recent Developments
10.5 Alnylam Pharmaceuticals
10.5.1 Alnylam Pharmaceuticals Basic Information
10.5.2 Alnylam Pharmaceuticals Gene Therapy Product Overview
10.5.3 Alnylam Pharmaceuticals Gene Therapy Product Market Performance
10.5.4 Alnylam Pharmaceuticals Business Overview
10.5.5 Alnylam Pharmaceuticals Recent Developments
10.6 Amgen
10.6.1 Amgen Basic Information
10.6.2 Amgen Gene Therapy Product Overview
10.6.3 Amgen Gene Therapy Product Market Performance
10.6.4 Amgen Business Overview
10.6.5 Amgen Recent Developments
10.7 Roche
10.7.1 Roche Basic Information
10.7.2 Roche Gene Therapy Product Overview
10.7.3 Roche Gene Therapy Product Market Performance
10.7.4 Roche Business Overview
10.7.5 Roche Recent Developments
10.8 Akcea Therapeutics
10.8.1 Akcea Therapeutics Basic Information
10.8.2 Akcea Therapeutics Gene Therapy Product Overview
10.8.3 Akcea Therapeutics Gene Therapy Product Market Performance
10.8.4 Akcea Therapeutics Business Overview
10.8.5 Akcea Therapeutics Recent Developments
10.9 bluebirdbio
10.9.1 bluebirdbio Basic Information
10.9.2 bluebirdbio Gene Therapy Product Overview
10.9.3 bluebirdbio Gene Therapy Product Market Performance
10.9.4 bluebirdbio Business Overview
10.9.5 bluebirdbio Recent Developments
10.10 Sunway Biotech
10.10.1 Sunway Biotech Basic Information
10.10.2 Sunway Biotech Gene Therapy Product Overview
10.10.3 Sunway Biotech Gene Therapy Product Market Performance
10.10.4 Sunway Biotech Business Overview
10.10.5 Sunway Biotech Recent Developments
10.11 SIBIONO
10.11.1 SIBIONO Basic Information
10.11.2 SIBIONO Gene Therapy Product Overview
10.11.3 SIBIONO Gene Therapy Product Market Performance
10.11.4 SIBIONO Business Overview
10.11.5 SIBIONO Recent Developments
10.12 AnGes
10.12.1 AnGes Basic Information
10.12.2 AnGes Gene Therapy Product Overview
10.12.3 AnGes Gene Therapy Product Market Performance
10.12.4 AnGes Business Overview
10.12.5 AnGes Recent Developments
10.13 Orchard Therapeutics
10.13.1 Orchard Therapeutics Basic Information
10.13.2 Orchard Therapeutics Gene Therapy Product Overview
10.13.3 Orchard Therapeutics Gene Therapy Product Market Performance
10.13.4 Orchard Therapeutics Business Overview
10.13.5 Orchard Therapeutics Recent Developments
10.14 Human Stem Cells Institute
10.14.1 Human Stem Cells Institute Basic Information
10.14.2 Human Stem Cells Institute Gene Therapy Product Overview
10.14.3 Human Stem Cells Institute Gene Therapy Product Market Performance
10.14.4 Human Stem Cells Institute Business Overview
10.14.5 Human Stem Cells Institute Recent Developments
10.15 CSL Behring
10.15.1 CSL Behring Basic Information
10.15.2 CSL Behring Gene Therapy Product Overview
10.15.3 CSL Behring Gene Therapy Product Market Performance
10.15.4 CSL Behring Business Overview
10.15.5 CSL Behring Recent Developments
10.16 BioMarin Pharmaceutical
10.16.1 BioMarin Pharmaceutical Basic Information
10.16.2 BioMarin Pharmaceutical Gene Therapy Product Overview
10.16.3 BioMarin Pharmaceutical Gene Therapy Product Market Performance
10.16.4 BioMarin Pharmaceutical Business Overview
10.16.5 BioMarin Pharmaceutical Recent Developments
11 GENE THERAPY MARKET FORECAST BY REGION
11.1 Global Gene Therapy Market Size Forecast
11.2 Global Gene Therapy Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Gene Therapy Market Size Forecast by Country
11.2.3 Asia Pacific Gene Therapy Market Size Forecast by Region
11.2.4 South America Gene Therapy Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Gene Therapy by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Gene Therapy Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Gene Therapy by Type (2026-2035)
12.1.2 Global Gene Therapy Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Gene Therapy by Type (2026-2035)
12.2 Global Gene Therapy Market Forecast by Application (2026-2035)
12.2.1 Global Gene Therapy Sales (K Units) Forecast by Application
12.2.2 Global Gene Therapy Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Gene Therapy Market Size by Type (M USD)
Table 4. Global Gene Therapy Market Size by Application
Table 5. Gene Therapy Market Size Comparison by Region (M USD)
Table 6. Global Gene Therapy Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Gene Therapy Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Gene Therapy Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Gene Therapy Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy as of 2025)
Table 11. Global Market Gene Therapy Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers’ Manufacturing Sites, Areas Served
Table 13. Manufacturers’ Product Type
Table 14. Global Gene Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Gene Therapy Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Gene Therapy Sales by Type (K Units)
Table 27. Global Gene Therapy Market Size by Type (M USD)
Table 28. Global Gene Therapy Sales (K Units) by Type (2020-2025)
Table 29. Global Gene Therapy Sales Market Share by Type (2020-2025)
Table 30. Global Gene Therapy Market Size (M USD) by Type (2020-2025)
Table 31. Global Gene Therapy Market Share by Type (2020-2025)
Table 32. Global Gene Therapy Price (USD/Unit) by Type (2020-2025)
Table 33. Global Gene Therapy Sales (K Units) by Application
Table 34. Global Gene Therapy Market Size by Application
Table 35. Global Gene Therapy Sales by Application (2020-2025) & (K Units)
Table 36. Global Gene Therapy Sales Market Share by Application (2020-2025)
Table 37. Global Gene Therapy Market Size by Application (2020-2025) & (M USD)
Table 38. Global Gene Therapy Market Share by Application (2020-2025)
Table 39. Global Gene Therapy Sales Growth Rate by Application (2020-2025)
Table 40. Global Gene Therapy Sales by Region (2020-2025) & (K Units)
Table 41. Global Gene Therapy Sales Market Share by Region (2020-2025)
Table 42. Global Gene Therapy Market Size by Region (2020-2025) & (M USD)
Table 43. Global Gene Therapy Market Size by Region (2020-2025)
Table 44. North America Gene Therapy Sales by Country (2020-2025) & (K Units)
Table 45. North America Gene Therapy Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Gene Therapy Sales by Country (2020-2025) & (K Units)
Table 47. Europe Gene Therapy Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Gene Therapy Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Gene Therapy Market Size by Region (2020-2025) & (M USD)
Table 50. South America Gene Therapy Sales by Country (2020-2025) & (K Units)
Table 51. South America Gene Therapy Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Gene Therapy Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Gene Therapy Market Size by Region (2020-2025) & (M USD)
Table 54. Global Gene Therapy Production (K Units) by Region(2020-2025)
Table 55. Global Gene Therapy Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Gene Therapy Revenue Market Share by Region (2020-2025)
Table 57. Global Gene Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Gene Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Gene Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Gene Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Gene Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Biogen Basic Information
Table 63. Biogen Gene Therapy Product Overview
Table 64. Biogen Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Biogen Business Overview
Table 66. Biogen SWOT Analysis
Table 67. Biogen Recent Developments
Table 68. Novartis Basic Information
Table 69. Novartis Gene Therapy Product Overview
Table 70. Novartis Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Novartis Business Overview
Table 72. Novartis SWOT Analysis
Table 73. Novartis Recent Developments
Table 74. Gilead Sciences Basic Information
Table 75. Gilead Sciences Gene Therapy Product Overview
Table 76. Gilead Sciences Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Gilead Sciences Business Overview
Table 78. Gilead Sciences SWOT Analysis
Table 79. Gilead Sciences Recent Developments
Table 80. Sarepta Therapeutics Basic Information
Table 81. Sarepta Therapeutics Gene Therapy Product Overview
Table 82. Sarepta Therapeutics Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Sarepta Therapeutics Business Overview
Table 84. Sarepta Therapeutics Recent Developments
Table 85. Alnylam Pharmaceuticals Basic Information
Table 86. Alnylam Pharmaceuticals Gene Therapy Product Overview
Table 87. Alnylam Pharmaceuticals Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Alnylam Pharmaceuticals Business Overview
Table 89. Alnylam Pharmaceuticals Recent Developments
Table 90. Amgen Basic Information
Table 91. Amgen Gene Therapy Product Overview
Table 92. Amgen Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Amgen Business Overview
Table 94. Amgen Recent Developments
Table 95. Roche Basic Information
Table 96. Roche Gene Therapy Product Overview
Table 97. Roche Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Roche Business Overview
Table 99. Roche Recent Developments
Table 100. Akcea Therapeutics Basic Information
Table 101. Akcea Therapeutics Gene Therapy Product Overview
Table 102. Akcea Therapeutics Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Akcea Therapeutics Business Overview
Table 104. Akcea Therapeutics Recent Developments
Table 105. bluebirdbio Basic Information
Table 106. bluebirdbio Gene Therapy Product Overview
Table 107. bluebirdbio Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. bluebirdbio Business Overview
Table 109. bluebirdbio Recent Developments
Table 110. Sunway Biotech Basic Information
Table 111. Sunway Biotech Gene Therapy Product Overview
Table 112. Sunway Biotech Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Sunway Biotech Business Overview
Table 114. Sunway Biotech Recent Developments
Table 115. SIBIONO Basic Information
Table 116. SIBIONO Gene Therapy Product Overview
Table 117. SIBIONO Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. SIBIONO Business Overview
Table 119. SIBIONO Recent Developments
Table 120. AnGes Basic Information
Table 121. AnGes Gene Therapy Product Overview
Table 122. AnGes Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. AnGes Business Overview
Table 124. AnGes Recent Developments
Table 125. Orchard Therapeutics Basic Information
Table 126. Orchard Therapeutics Gene Therapy Product Overview
Table 127. Orchard Therapeutics Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Orchard Therapeutics Business Overview
Table 129. Orchard Therapeutics Recent Developments
Table 130. Human Stem Cells Institute Basic Information
Table 131. Human Stem Cells Institute Gene Therapy Product Overview
Table 132. Human Stem Cells Institute Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Human Stem Cells Institute Business Overview
Table 134. Human Stem Cells Institute Recent Developments
Table 135. CSL Behring Basic Information
Table 136. CSL Behring Gene Therapy Product Overview
Table 137. CSL Behring Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. CSL Behring Business Overview
Table 139. CSL Behring Recent Developments
Table 140. BioMarin Pharmaceutical Basic Information
Table 141. BioMarin Pharmaceutical Gene Therapy Product Overview
Table 142. BioMarin Pharmaceutical Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 143. BioMarin Pharmaceutical Business Overview
Table 144. BioMarin Pharmaceutical Recent Developments
Table 145. Global Gene Therapy Sales Forecast by Region (2026-2035) & (K Units)
Table 146. Global Gene Therapy Market Size Forecast by Region (2026-2035) & (M USD)
Table 147. North America Gene Therapy Sales Forecast by Country (2026-2035) & (K Units)
Table 148. North America Gene Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 149. Europe Gene Therapy Sales Forecast by Country (2026-2035) & (K Units)
Table 150. Europe Gene Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 151. Asia Pacific Gene Therapy Sales Forecast by Region (2026-2035) & (K Units)
Table 152. Asia Pacific Gene Therapy Market Size Forecast by Region (2026-2035) & (M USD)
Table 153. South America Gene Therapy Sales Forecast by Country (2026-2035) & (K Units)
Table 154. South America Gene Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 155. Middle East and Africa Gene Therapy Sales Forecast by Country (2026-2035) & (Units)
Table 156. Middle East and Africa Gene Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 157. Global Gene Therapy Sales Forecast by Type (2026-2035) & (K Units)
Table 158. Global Gene Therapy Market Size Forecast by Type (2026-2035) & (M USD)
Table 159. Global Gene Therapy Price Forecast by Type (2026-2035) & (USD/Unit)
Table 160. Global Gene Therapy Sales (K Units) Forecast by Application (2026-2035)
Table 161. Global Gene Therapy Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Gene Therapy Market Size by Type (M USD)
Table 4. Global Gene Therapy Market Size by Application
Table 5. Gene Therapy Market Size Comparison by Region (M USD)
Table 6. Global Gene Therapy Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Gene Therapy Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Gene Therapy Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Gene Therapy Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy as of 2025)
Table 11. Global Market Gene Therapy Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers’ Manufacturing Sites, Areas Served
Table 13. Manufacturers’ Product Type
Table 14. Global Gene Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Gene Therapy Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Gene Therapy Sales by Type (K Units)
Table 27. Global Gene Therapy Market Size by Type (M USD)
Table 28. Global Gene Therapy Sales (K Units) by Type (2020-2025)
Table 29. Global Gene Therapy Sales Market Share by Type (2020-2025)
Table 30. Global Gene Therapy Market Size (M USD) by Type (2020-2025)
Table 31. Global Gene Therapy Market Share by Type (2020-2025)
Table 32. Global Gene Therapy Price (USD/Unit) by Type (2020-2025)
Table 33. Global Gene Therapy Sales (K Units) by Application
Table 34. Global Gene Therapy Market Size by Application
Table 35. Global Gene Therapy Sales by Application (2020-2025) & (K Units)
Table 36. Global Gene Therapy Sales Market Share by Application (2020-2025)
Table 37. Global Gene Therapy Market Size by Application (2020-2025) & (M USD)
Table 38. Global Gene Therapy Market Share by Application (2020-2025)
Table 39. Global Gene Therapy Sales Growth Rate by Application (2020-2025)
Table 40. Global Gene Therapy Sales by Region (2020-2025) & (K Units)
Table 41. Global Gene Therapy Sales Market Share by Region (2020-2025)
Table 42. Global Gene Therapy Market Size by Region (2020-2025) & (M USD)
Table 43. Global Gene Therapy Market Size by Region (2020-2025)
Table 44. North America Gene Therapy Sales by Country (2020-2025) & (K Units)
Table 45. North America Gene Therapy Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Gene Therapy Sales by Country (2020-2025) & (K Units)
Table 47. Europe Gene Therapy Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Gene Therapy Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Gene Therapy Market Size by Region (2020-2025) & (M USD)
Table 50. South America Gene Therapy Sales by Country (2020-2025) & (K Units)
Table 51. South America Gene Therapy Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Gene Therapy Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Gene Therapy Market Size by Region (2020-2025) & (M USD)
Table 54. Global Gene Therapy Production (K Units) by Region(2020-2025)
Table 55. Global Gene Therapy Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Gene Therapy Revenue Market Share by Region (2020-2025)
Table 57. Global Gene Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Gene Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Gene Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Gene Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Gene Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Biogen Basic Information
Table 63. Biogen Gene Therapy Product Overview
Table 64. Biogen Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Biogen Business Overview
Table 66. Biogen SWOT Analysis
Table 67. Biogen Recent Developments
Table 68. Novartis Basic Information
Table 69. Novartis Gene Therapy Product Overview
Table 70. Novartis Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Novartis Business Overview
Table 72. Novartis SWOT Analysis
Table 73. Novartis Recent Developments
Table 74. Gilead Sciences Basic Information
Table 75. Gilead Sciences Gene Therapy Product Overview
Table 76. Gilead Sciences Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Gilead Sciences Business Overview
Table 78. Gilead Sciences SWOT Analysis
Table 79. Gilead Sciences Recent Developments
Table 80. Sarepta Therapeutics Basic Information
Table 81. Sarepta Therapeutics Gene Therapy Product Overview
Table 82. Sarepta Therapeutics Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Sarepta Therapeutics Business Overview
Table 84. Sarepta Therapeutics Recent Developments
Table 85. Alnylam Pharmaceuticals Basic Information
Table 86. Alnylam Pharmaceuticals Gene Therapy Product Overview
Table 87. Alnylam Pharmaceuticals Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Alnylam Pharmaceuticals Business Overview
Table 89. Alnylam Pharmaceuticals Recent Developments
Table 90. Amgen Basic Information
Table 91. Amgen Gene Therapy Product Overview
Table 92. Amgen Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Amgen Business Overview
Table 94. Amgen Recent Developments
Table 95. Roche Basic Information
Table 96. Roche Gene Therapy Product Overview
Table 97. Roche Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Roche Business Overview
Table 99. Roche Recent Developments
Table 100. Akcea Therapeutics Basic Information
Table 101. Akcea Therapeutics Gene Therapy Product Overview
Table 102. Akcea Therapeutics Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Akcea Therapeutics Business Overview
Table 104. Akcea Therapeutics Recent Developments
Table 105. bluebirdbio Basic Information
Table 106. bluebirdbio Gene Therapy Product Overview
Table 107. bluebirdbio Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. bluebirdbio Business Overview
Table 109. bluebirdbio Recent Developments
Table 110. Sunway Biotech Basic Information
Table 111. Sunway Biotech Gene Therapy Product Overview
Table 112. Sunway Biotech Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Sunway Biotech Business Overview
Table 114. Sunway Biotech Recent Developments
Table 115. SIBIONO Basic Information
Table 116. SIBIONO Gene Therapy Product Overview
Table 117. SIBIONO Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. SIBIONO Business Overview
Table 119. SIBIONO Recent Developments
Table 120. AnGes Basic Information
Table 121. AnGes Gene Therapy Product Overview
Table 122. AnGes Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. AnGes Business Overview
Table 124. AnGes Recent Developments
Table 125. Orchard Therapeutics Basic Information
Table 126. Orchard Therapeutics Gene Therapy Product Overview
Table 127. Orchard Therapeutics Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Orchard Therapeutics Business Overview
Table 129. Orchard Therapeutics Recent Developments
Table 130. Human Stem Cells Institute Basic Information
Table 131. Human Stem Cells Institute Gene Therapy Product Overview
Table 132. Human Stem Cells Institute Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Human Stem Cells Institute Business Overview
Table 134. Human Stem Cells Institute Recent Developments
Table 135. CSL Behring Basic Information
Table 136. CSL Behring Gene Therapy Product Overview
Table 137. CSL Behring Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. CSL Behring Business Overview
Table 139. CSL Behring Recent Developments
Table 140. BioMarin Pharmaceutical Basic Information
Table 141. BioMarin Pharmaceutical Gene Therapy Product Overview
Table 142. BioMarin Pharmaceutical Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 143. BioMarin Pharmaceutical Business Overview
Table 144. BioMarin Pharmaceutical Recent Developments
Table 145. Global Gene Therapy Sales Forecast by Region (2026-2035) & (K Units)
Table 146. Global Gene Therapy Market Size Forecast by Region (2026-2035) & (M USD)
Table 147. North America Gene Therapy Sales Forecast by Country (2026-2035) & (K Units)
Table 148. North America Gene Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 149. Europe Gene Therapy Sales Forecast by Country (2026-2035) & (K Units)
Table 150. Europe Gene Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 151. Asia Pacific Gene Therapy Sales Forecast by Region (2026-2035) & (K Units)
Table 152. Asia Pacific Gene Therapy Market Size Forecast by Region (2026-2035) & (M USD)
Table 153. South America Gene Therapy Sales Forecast by Country (2026-2035) & (K Units)
Table 154. South America Gene Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 155. Middle East and Africa Gene Therapy Sales Forecast by Country (2026-2035) & (Units)
Table 156. Middle East and Africa Gene Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 157. Global Gene Therapy Sales Forecast by Type (2026-2035) & (K Units)
Table 158. Global Gene Therapy Market Size Forecast by Type (2026-2035) & (M USD)
Table 159. Global Gene Therapy Price Forecast by Type (2026-2035) & (USD/Unit)
Table 160. Global Gene Therapy Sales (K Units) Forecast by Application (2026-2035)
Table 161. Global Gene Therapy Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Gene Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Gene Therapy Market Size (M USD), 2025-2035
Figure 5. Global Gene Therapy Market Size (M USD) (2020-2035)
Figure 6. Global Gene Therapy Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Gene Therapy Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Gene Therapy Product Life Cycle
Figure 13. Gene Therapy Sales Share by Manufacturers in 2025
Figure 14. Global Gene Therapy Revenue Share by Manufacturers in 2025
Figure 15. Gene Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Gene Therapy Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Gene Therapy Revenue in 2025
Figure 18. Industry Chain Map of Gene Therapy
Figure 19. Global Gene Therapy Market PEST Analysis
Figure 20. Global Gene Therapy Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Gene Therapy Market Share by Type
Figure 27. Sales Market Share of Gene Therapy by Type (2020-2025)
Figure 28. Sales Market Share of Gene Therapy by Type in 2025
Figure 29. Market Share of Gene Therapy by Type (2020-2025)
Figure 30. Market Share of Gene Therapy by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Gene Therapy Market Share by Application
Figure 33. Global Gene Therapy Sales Market Share by Application (2020-2025)
Figure 34. Global Gene Therapy Sales Market Share by Application in 2025
Figure 35. Global Gene Therapy Market Share by Application (2020-2025)
Figure 36. Global Gene Therapy Market Share by Application in 2025
Figure 37. Global Gene Therapy Sales Growth Rate by Application (2020-2025)
Figure 38. Global Gene Therapy Sales Market Share by Region (2020-2025)
Figure 39. Global Gene Therapy Market Size by Region (2020-2025)
Figure 40. North America Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Gene Therapy Sales Market Share by Country in 2024
Figure 43. North America Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Gene Therapy Market Size by Country in 2024
Figure 45. U.S. Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Gene Therapy Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Gene Therapy Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Gene Therapy Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Gene Therapy Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Gene Therapy Sales Market Share by Country in 2024
Figure 53. Europe Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Gene Therapy Market Size by Country in 2024
Figure 55. Germany Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Gene Therapy Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Gene Therapy Sales Market Share by Region in 2024
Figure 67. Asia Pacific Gene Therapy Market Size by Region in 2024
Figure 68. China Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Gene Therapy Sales and Growth Rate (K Units)
Figure 79. South America Gene Therapy Sales Market Share by Country in 2024
Figure 80. South America Gene Therapy Market Size and Growth Rate (M USD)
Figure 81. South America Gene Therapy Market Size by Country in 2024
Figure 82. Brazil Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Gene Therapy Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Gene Therapy Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Gene Therapy Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Gene Therapy Market Size by Region in 2024
Figure 92. Saudi Arabia Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Gene Therapy Production Market Share by Region (2020-2025)
Figure 103. North America Gene Therapy Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Gene Therapy Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Gene Therapy Production (K Units) Growth Rate (2020-2025)
Figure 106. China Gene Therapy Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Gene Therapy Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Gene Therapy Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Gene Therapy Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Gene Therapy Market Share Forecast by Type (2026-2035)
Figure 111. Global Gene Therapy Sales Forecast by Application (2026-2035)
Figure 112. Global Gene Therapy Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Gene Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Gene Therapy Market Size (M USD), 2025-2035
Figure 5. Global Gene Therapy Market Size (M USD) (2020-2035)
Figure 6. Global Gene Therapy Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Gene Therapy Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Gene Therapy Product Life Cycle
Figure 13. Gene Therapy Sales Share by Manufacturers in 2025
Figure 14. Global Gene Therapy Revenue Share by Manufacturers in 2025
Figure 15. Gene Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Gene Therapy Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Gene Therapy Revenue in 2025
Figure 18. Industry Chain Map of Gene Therapy
Figure 19. Global Gene Therapy Market PEST Analysis
Figure 20. Global Gene Therapy Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Gene Therapy Market Share by Type
Figure 27. Sales Market Share of Gene Therapy by Type (2020-2025)
Figure 28. Sales Market Share of Gene Therapy by Type in 2025
Figure 29. Market Share of Gene Therapy by Type (2020-2025)
Figure 30. Market Share of Gene Therapy by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Gene Therapy Market Share by Application
Figure 33. Global Gene Therapy Sales Market Share by Application (2020-2025)
Figure 34. Global Gene Therapy Sales Market Share by Application in 2025
Figure 35. Global Gene Therapy Market Share by Application (2020-2025)
Figure 36. Global Gene Therapy Market Share by Application in 2025
Figure 37. Global Gene Therapy Sales Growth Rate by Application (2020-2025)
Figure 38. Global Gene Therapy Sales Market Share by Region (2020-2025)
Figure 39. Global Gene Therapy Market Size by Region (2020-2025)
Figure 40. North America Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Gene Therapy Sales Market Share by Country in 2024
Figure 43. North America Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Gene Therapy Market Size by Country in 2024
Figure 45. U.S. Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Gene Therapy Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Gene Therapy Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Gene Therapy Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Gene Therapy Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Gene Therapy Sales Market Share by Country in 2024
Figure 53. Europe Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Gene Therapy Market Size by Country in 2024
Figure 55. Germany Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Gene Therapy Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Gene Therapy Sales Market Share by Region in 2024
Figure 67. Asia Pacific Gene Therapy Market Size by Region in 2024
Figure 68. China Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Gene Therapy Sales and Growth Rate (K Units)
Figure 79. South America Gene Therapy Sales Market Share by Country in 2024
Figure 80. South America Gene Therapy Market Size and Growth Rate (M USD)
Figure 81. South America Gene Therapy Market Size by Country in 2024
Figure 82. Brazil Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Gene Therapy Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Gene Therapy Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Gene Therapy Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Gene Therapy Market Size by Region in 2024
Figure 92. Saudi Arabia Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Gene Therapy Production Market Share by Region (2020-2025)
Figure 103. North America Gene Therapy Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Gene Therapy Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Gene Therapy Production (K Units) Growth Rate (2020-2025)
Figure 106. China Gene Therapy Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Gene Therapy Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Gene Therapy Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Gene Therapy Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Gene Therapy Market Share Forecast by Type (2026-2035)
Figure 111. Global Gene Therapy Sales Forecast by Application (2026-2035)
Figure 112. Global Gene Therapy Market Share Forecast by Application (2026-2035)
More Publications
Global Electromagnetic Therapy Device Market Research Report 2025(Status and Outlook)
US$ 3,200.00
August 2025
153 pages
Global Tube Filler Market Research Report 2026(Status and Outlook)
US$ 3,200.00
March 2026
141 pages
Global Electric Winches Market Research Report 2026(Status and Outlook)
US$ 2,980.00
March 2026
164 pages
Global Hand Trucks Market Research Report 2026(Status and Outlook)
US$ 3,200.00
May 2026
149 pages
Global Composite SCBA Cylinders Market Research Report 2026(Status and Outlook)
US$ 3,200.00
May 2026
156 pages
